首页 > 最新文献

Annales de cardiologie et d'angeiologie最新文献

英文 中文
Artériopathie oblitérante des membres inférieurs chez le sujet diabétique noir africain : profil épidémioclinique, ultrasonographique et facteurs déterminants 非洲黑人糖尿病患者下肢闭塞性动脉病变:流行病学和超声波图谱及决定因素
IF 0.3 Q4 Medicine Pub Date : 2024-04-17 DOI: 10.1016/j.ancard.2024.101736
Oumar Mahamat-Azaki , Abdel-madjid Zakaria Zakaria , Abba Oumar , Yaya kichiné Mahamat , Adam Ahamat Ali , Deneube Lackdjoulki , Esaie Soya

Background

Diabetes can lead to micro and macro-angiopathies. The peripheral arterial disease (PAD) is a serious and an incapacitating disease. It is still under-estimated and under-treated throughout the world, particularly in sub-Saharan Africa. Doppler ultrasound, and in particular ankle brachial index (ABI), can be used to detect it. The aim was to determine the prevalence of PAD to study the clinical and ultrasonographic aspects and to identify the determining factors.

Patients and methods

This was a descriptive and analytical study over a period of 5 years, including a total of 782 diabetic patients hospitalised in the diabetology department of the CHU la Reference Nationale.

Results

Among the 782 patients, 166 (21.2%) had an ABI < 0.9 reflected the PAD and 72 (9.2%) had an ABI > 1.3, suggestive of mediacalcosis. PAD of the lower limb was mild in 102 patients (61.4%), moderate in (26.3%) and severe in (12.3%). The mean age of the arteritic patients was 56.4 ± 10.2 years. Male gender predominated (59.6%) with a sex ratio of 1.6. All patients had type 2 diabetes (100%). The mean duration of diabetes was 13 ± 5.9 years. The majority of our patients with arterial disease had diabetes for at least 10 years (54.2%). The other cardiovascular in this population were obesity (45.2%), followed by hypertension and dyslipidaemia (32.5%). Diabetes was unbalanced (HbA ≥7%) in the majority of cases (75.3%). Clinically, the majority of patients had a trophic disorder (68%). Asymptomatic patients accounted for 24.6% of cases and those with intermittent claudication for 7.4%. Duplex doppler of the lower limbs showed that all patients with PAD had atheromatous lesions. The distal location was predominantly in the tibial arteries (54.8%). The determinants of PAD in this diabetic population were hypertension (p = 0.01) and obesity (p = 0.01).

Conclusion

In our series, PAD was often discovered at an advanced stage, with a non-negligible prevalence. The determining factors found were hypertension and obesity. Screening and control of major cardiovascular risk factors is a priority in the management of this disease.

背景糖尿病可导致微血管病变和大血管病变。外周动脉疾病(PAD)是一种严重的致残性疾病。全世界,尤其是撒哈拉以南非洲地区,对这种疾病的估计和治疗仍然不足。多普勒超声,尤其是踝肱指数(ABI),可用于检测这种疾病。患者和方法这是一项描述性和分析性研究,历时5年,共包括782名在CHU la Reference Nationale糖尿病科住院的糖尿病患者。结果在782名患者中,166人(21.2%)的ABI大于0.9,反映出有PAD;72人(9.2%)的ABI大于1.3,提示有中度钙化。102 名患者(61.4%)的下肢 PAD 为轻度,26.3% 为中度,12.3% 为重度。动脉粥样硬化患者的平均年龄为(56.4 ± 10.2)岁。男性占多数(59.6%),性别比为 1.6。所有患者均患有 2 型糖尿病(100%)。平均糖尿病病程为(13 ± 5.9)年。大多数动脉疾病患者的糖尿病病程至少为 10 年(54.2%)。该人群的其他心血管疾病是肥胖(45.2%),其次是高血压和血脂异常(32.5%)。大多数病例(75.3%)的糖尿病不均衡(HbA ≥7%)。临床上,大多数患者患有营养障碍(68%)。无症状患者占 24.6%,间歇性跛行患者占 7.4%。下肢双工多普勒显示,所有 PAD 患者都有动脉粥样硬化病变。远端病变主要位于胫动脉(54.8%)。结论在我们的系列研究中,PAD 通常在晚期才被发现,发病率不容忽视。高血压和肥胖是决定性因素。筛查和控制主要的心血管风险因素是治疗这种疾病的首要任务。
{"title":"Artériopathie oblitérante des membres inférieurs chez le sujet diabétique noir africain : profil épidémioclinique, ultrasonographique et facteurs déterminants","authors":"Oumar Mahamat-Azaki ,&nbsp;Abdel-madjid Zakaria Zakaria ,&nbsp;Abba Oumar ,&nbsp;Yaya kichiné Mahamat ,&nbsp;Adam Ahamat Ali ,&nbsp;Deneube Lackdjoulki ,&nbsp;Esaie Soya","doi":"10.1016/j.ancard.2024.101736","DOIUrl":"https://doi.org/10.1016/j.ancard.2024.101736","url":null,"abstract":"<div><h3>Background</h3><p>Diabetes can lead to micro and macro-angiopathies. The peripheral arterial disease (PAD) is a serious and an incapacitating disease. It is still under-estimated and under-treated throughout the world, particularly in sub-Saharan Africa. Doppler ultrasound, and in particular ankle brachial index (ABI), can be used to detect it. The aim was to determine the prevalence of PAD to study the clinical and ultrasonographic aspects and to identify the determining factors.</p></div><div><h3>Patients and methods</h3><p>This was a descriptive and analytical study over a period of 5 years, including a total of 782 diabetic patients hospitalised in the diabetology department of the CHU la Reference Nationale.</p></div><div><h3>Results</h3><p>Among the 782 patients, 166 (21.2%) had an ABI &lt; 0.9 reflected the PAD and 72 (9.2%) had an ABI &gt; 1.3, suggestive of mediacalcosis. PAD of the lower limb was mild in 102 patients (61.4%), moderate in (26.3%) and severe in (12.3%). The mean age of the arteritic patients was 56.4 ± 10.2 years. Male gender predominated (59.6%) with a sex ratio of 1.6. All patients had type 2 diabetes (100%). The mean duration of diabetes was 13 ± 5.9 years. The majority of our patients with arterial disease had diabetes for at least 10 years (54.2%). The other cardiovascular in this population were obesity (45.2%), followed by hypertension and dyslipidaemia (32.5%). Diabetes was unbalanced (HbA ≥7%) in the majority of cases (75.3%). Clinically, the majority of patients had a trophic disorder (68%). Asymptomatic patients accounted for 24.6% of cases and those with intermittent claudication for 7.4%. Duplex doppler of the lower limbs showed that all patients with PAD had atheromatous lesions. The distal location was predominantly in the tibial arteries (54.8%). The determinants of PAD in this diabetic population were hypertension (<em>p</em> = 0.01) and obesity (<em>p</em> = 0.01).</p></div><div><h3>Conclusion</h3><p>In our series, PAD was often discovered at an advanced stage, with a non-negligible prevalence. The determining factors found were hypertension and obesity. Screening and control of major cardiovascular risk factors is a priority in the management of this disease.</p></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 3","pages":"Article 101736"},"PeriodicalIF":0.3,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140558150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial board / Ours rédaction 编辑部 / Ours rédaction
IF 0.3 Q4 Medicine Pub Date : 2024-03-27 DOI: 10.1016/S0003-3928(24)00026-X
{"title":"Editorial board / Ours rédaction","authors":"","doi":"10.1016/S0003-3928(24)00026-X","DOIUrl":"https://doi.org/10.1016/S0003-3928(24)00026-X","url":null,"abstract":"","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101747"},"PeriodicalIF":0.3,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S000339282400026X/pdfft?md5=4cad823c46468c23399e28266659fe94&pid=1-s2.0-S000339282400026X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140309858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sommaire 目录
IF 0.3 Q4 Medicine Pub Date : 2024-03-27 DOI: 10.1016/S0003-3928(24)00029-5
{"title":"Sommaire","authors":"","doi":"10.1016/S0003-3928(24)00029-5","DOIUrl":"https://doi.org/10.1016/S0003-3928(24)00029-5","url":null,"abstract":"","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101750"},"PeriodicalIF":0.3,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0003392824000295/pdfft?md5=fdfc7d9b3562ec5ef220ec5f025e6a6b&pid=1-s2.0-S0003392824000295-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140309859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Apport du scanner cardiaque dans la prise en charge des cardiopathies congénitales : expérience de l'institut de cardiologie d'Abidjan à propos de 27 cas 心脏 CT 在先天性心脏病治疗中的贡献:阿比让心脏研究所在 27 个病例中的经验
IF 0.3 Q4 Medicine Pub Date : 2024-03-01 DOI: 10.1016/j.ancard.2024.101739
Ami Echua Manzan Avoh , Yves N'da Kouakou N'goran , Marie Paul N'cho-Mottoh , Diaby Fatou Traore , Micesse Tano-Akoto , Cedrick Zole Doh , Legre Vy , Kacou Jean-Baptiste Anzouan , Kouadio Euloge Kramoh

Introduction and objectives

In contrast to developed countries, cardiac CT is not widely used in West Africa for the assessment of congenital heart disease, and has only recently been introduced in Côte d'Ivoire. The lack of data prompted this study, the aim of which was to describe our experience of the contribution of CT to the management of congenital heart disease in the Ivorian cardiology setting.

Patients and method

This was a prospective study which took place in the pediatric cardiology department over a period of 9 months (September 2022 to June 2023) which included all patients with congenital heart disease explored by echocardiography and cardiac scan.

Results

The average age was 5.7 ± 4.7 years with extremes of 5 months and 16 years. We noted a female predominance with a sex ratio of 0.52. The main heart diseases were: tetralogy of Fallot (37.1%), followed by pulmonary atresia with open septum (18.52%). The assessment of the anatomy of the pulmonary arteries (81.48%), the search for aortopulmonary collaterals (59.63%) and finally the assessment of the anatomy of the aorta (18.52%) were the main indications. The practice of cardiac CT scanning has enabled better accuracy in the diagnosis and management of congenital heart disease in several cases: an interruption of the aortic arch was found in 1 case initially suspected of hypoplasia of the aortic arch, three cases of partial abnormal pulmonary venous return and one case of total abnormal pulmonary venous return. Also, agenesis of the left pulmonary artery with birth anomaly of the right coronary artery in the assessment of tetralogy of Fallot was found in 1 case. The CT scan made it possible to specify the exact topography of the aortopulmonary collaterals in four cases of pulmonary atresia with an open septum.

Conclusion

CT has enabled better visualization of the arterial and venous pulmonary tree, identification and exact localization of aorto-pulmonary collaterals, precise description of the three-dimensional anatomy of the coronary arteries, and better precision of congenital anomalies of the aorta.

导言和目的与发达国家相比,心脏 CT 在西非并没有被广泛用于评估先天性心脏病,科特迪瓦也是最近才引入 CT。患者和方法这是一项前瞻性研究,在小儿心脏科进行,为期 9 个月(2022 年 9 月至 2023 年 6 月),包括所有通过超声心动图和心脏扫描检查的先天性心脏病患者。结果平均年龄为 5.7 ± 4.7 岁,最大年龄为 5 个月和 16 岁。我们注意到女性居多,性别比为 0.52。主要的心脏疾病有:法洛氏四联症(37.1%),其次是肺动脉闭锁伴房间隔开放(18.52%)。评估肺动脉的解剖结构(81.48%)、寻找主动脉肺动脉袢(59.63%)和评估主动脉的解剖结构(18.52%)是主要的适应症。心脏 CT 扫描的应用使一些先天性心脏病的诊断和治疗更加准确:1 例最初怀疑主动脉弓发育不良的病例发现主动脉弓中断,3 例部分肺静脉回流异常,1 例完全肺静脉回流异常。此外,在评估法洛氏四联症时发现 1 例左肺动脉发育不全,右冠状动脉先天异常。结论 CT 使肺动脉和肺静脉树的可视化程度更高,可识别并准确定位主动脉-肺动脉袢,精确描述冠状动脉的三维解剖结构,并能更准确地诊断先天性主动脉异常。
{"title":"Apport du scanner cardiaque dans la prise en charge des cardiopathies congénitales : expérience de l'institut de cardiologie d'Abidjan à propos de 27 cas","authors":"Ami Echua Manzan Avoh ,&nbsp;Yves N'da Kouakou N'goran ,&nbsp;Marie Paul N'cho-Mottoh ,&nbsp;Diaby Fatou Traore ,&nbsp;Micesse Tano-Akoto ,&nbsp;Cedrick Zole Doh ,&nbsp;Legre Vy ,&nbsp;Kacou Jean-Baptiste Anzouan ,&nbsp;Kouadio Euloge Kramoh","doi":"10.1016/j.ancard.2024.101739","DOIUrl":"https://doi.org/10.1016/j.ancard.2024.101739","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>In contrast to developed countries, cardiac CT is not widely used in West Africa for the assessment of congenital heart disease, and has only recently been introduced in Côte d'Ivoire. The lack of data prompted this study, the aim of which was to describe our experience of the contribution of CT to the management of congenital heart disease in the Ivorian cardiology setting.</p></div><div><h3>Patients and method</h3><p>This was a prospective study which took place in the pediatric cardiology department over a period of 9 months (September 2022 to June 2023) which included all patients with congenital heart disease explored by echocardiography and cardiac scan.</p></div><div><h3>Results</h3><p>The average age was 5.7 ± 4.7 years with extremes of 5 months and 16 years. We noted a female predominance with a sex ratio of 0.52. The main heart diseases were: tetralogy of Fallot (37.1%), followed by pulmonary atresia with open septum (18.52%). The assessment of the anatomy of the pulmonary arteries (81.48%), the search for aortopulmonary collaterals (59.63%) and finally the assessment of the anatomy of the aorta (18.52%) were the main indications. The practice of cardiac CT scanning has enabled better accuracy in the diagnosis and management of congenital heart disease in several cases: an interruption of the aortic arch was found in 1 case initially suspected of hypoplasia of the aortic arch, three cases of partial abnormal pulmonary venous return and one case of total abnormal pulmonary venous return. Also, agenesis of the left pulmonary artery with birth anomaly of the right coronary artery in the assessment of tetralogy of Fallot was found in 1 case. The CT scan made it possible to specify the exact topography of the aortopulmonary collaterals in four cases of pulmonary atresia with an open septum.</p></div><div><h3>Conclusion</h3><p>CT has enabled better visualization of the arterial and venous pulmonary tree, identification and exact localization of aorto-pulmonary collaterals, precise description of the three-dimensional anatomy of the coronary arteries, and better precision of congenital anomalies of the aorta.</p></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 3","pages":"Article 101739"},"PeriodicalIF":0.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140000322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endocardite infectieuse : facteurs prédictifs de mortalité intrahospitalière 感染性心内膜炎:预测院内死亡率的因素
IF 0.3 Q4 Medicine Pub Date : 2024-02-27 DOI: 10.1016/j.ancard.2024.101740
Othmani Safia , Jendoubi Asma , Hedhli Hana , Jouini Sarra , Zoubli Aymen , Jemai Mouna , Maaref Amal , Ben Kaddour Rym

Introduction

Infective endocarditis (IE) remains a serious disease with significant morbidity and mortality despite therapeutic advancements. The aim of our study was to determine the predictive factors of in-hospital mortality.

Patients and methods

A prospective comparative study over a period of 54 months was conducted, including all patients admitted for definite infective endocarditis, diagnosed according to the modified Duke criteria published in 2015 by the European Society of Cardiology.

Results

Thirty-four patients were included. Drug addiction was the main risk factor for infective endocarditis (56%). Tricuspid valve involvement was predominant (50%). Staphylococcus aureus was the most commonly isolated pathogen (65%). In-hospital mortality rate was 47%. In multivariate analysis, predictive factors for mortality were acute heart failure (OR=7.4; p=0.026; 95% CI [1.2–44]) and cerebral embolic localization (OR=11.1; p=0.024; 95% CI [13–90]).

Conclusions

Cardiac and cerebral complications influence the prognosis of IE. Thus, close collaboration among multidisciplinary teams is necessary for improved diagnostic and therapeutic management.

导言感染性心内膜炎(IE)是一种严重的疾病,尽管治疗手段不断进步,但发病率和死亡率仍然很高。我们的研究旨在确定院内死亡率的预测因素。患者和方法 我们开展了一项为期 54 个月的前瞻性比较研究,研究对象包括所有确诊为感染性心内膜炎的住院患者,诊断标准为欧洲心脏病学会 2015 年发布的修订版杜克标准。吸毒是感染性心内膜炎的主要风险因素(56%)。三尖瓣主要受累(50%)。金黄色葡萄球菌是最常见的分离病原体(65%)。院内死亡率为 47%。在多变量分析中,预测死亡率的因素是急性心力衰竭(OR=7.4;P=0.026;95% CI [1.2-44])和脑栓塞定位(OR=11.1;P=0.024;95% CI [13-90])。结论心脑并发症会影响 IE 的预后,因此多学科团队之间必须密切合作,以改善诊断和治疗管理。
{"title":"Endocardite infectieuse : facteurs prédictifs de mortalité intrahospitalière","authors":"Othmani Safia ,&nbsp;Jendoubi Asma ,&nbsp;Hedhli Hana ,&nbsp;Jouini Sarra ,&nbsp;Zoubli Aymen ,&nbsp;Jemai Mouna ,&nbsp;Maaref Amal ,&nbsp;Ben Kaddour Rym","doi":"10.1016/j.ancard.2024.101740","DOIUrl":"https://doi.org/10.1016/j.ancard.2024.101740","url":null,"abstract":"<div><h3>Introduction</h3><p>Infective endocarditis (IE) remains a serious disease with significant morbidity and mortality despite therapeutic advancements. The aim of our study was to determine the predictive factors of in-hospital mortality.</p></div><div><h3>Patients and methods</h3><p>A prospective comparative study over a period of 54 months was conducted, including all patients admitted for definite infective endocarditis, diagnosed according to the modified Duke criteria published in 2015 by the European Society of Cardiology.</p></div><div><h3>Results</h3><p>Thirty-four patients were included. Drug addiction was the main risk factor for infective endocarditis (56%). Tricuspid valve involvement was predominant (50%). <em>Staphylococcus aureus</em> was the most commonly isolated pathogen (65%). In-hospital mortality rate was 47%. In multivariate analysis, predictive factors for mortality were acute heart failure (OR=7.4; <em>p</em>=0.026; 95% CI [1.2–44]) and cerebral embolic localization (OR=11.1; <em>p</em>=0.024; 95% CI [13–90]).</p></div><div><h3>Conclusions</h3><p>Cardiac and cerebral complications influence the prognosis of IE. Thus, close collaboration among multidisciplinary teams is necessary for improved diagnostic and therapeutic management.</p></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101740"},"PeriodicalIF":0.3,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139985475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pronostic comparé de l'embolie pulmonaire chez les patients infectés au COVID-19 et les patients non infectés au COVID-19 à Ouagadougou 瓦加杜古感染 COVID-19 和未感染 COVID-19 的患者肺栓塞预后比较
IF 0.3 Q4 Medicine Pub Date : 2024-02-21 DOI: 10.1016/j.ancard.2024.101735
Y. Kambiré , G.R.C. Millogo , K.J. Kologo , A. Tall-Thiam , V. Agossou , L. Konaté , H. Somé , I. Diallo , N.V. Yameogo , K.A. Samadoulougou , P. Zabsonré

Objective

the study's objective was to determine impact of COVID-19 on the prognosis of pulmonary embolism.

Patients and methods

An analytical multicenter cross-sectional study with retrospective data collection was carried out in three university hospitals and a private clinic in Ouagadougou from March, 2020 to July 2021. It included consecutive patients hospitalized for PE confirmed on chest CT angiography or by the association an acute cor pulmonale on echocardiography-Doppler with deep vein thrombosis on venous ultrasound-Doppler of the lower limbs and having carried out a COVID-19 test (RT-PCR or rapid diagnostic test). Control cases consisted of all COVID-19 negative PE cases. Data comparison was carried out using the Epi info 7 software. A univariate then multivariate analysis allowed the comparison of the prognosis of the two subpopulations. The significance level retained was p < 0.05.

Results

96 patients with COVID-19+ and 70 COVID-19- PE were included. The prevalence of PE in patients hospitalized for COVID-19 was 7.05%. The average patient age was 61.5±17 years for COVID-19+ patients and 49.6±15.9 years for COVID-19- patients. Pulmonary condensation syndrome (p=0.007), desaturation (p=0.0003) and respiratory distress syndrome (p=0.006) were more common in COVID-19+ patients. The hospital death rate was 27.1% in COVID-19+ patients and 10% in COVID-19- patients (p=0.0024). Age > 65 years and COVID-19 pneumonia were the independent factors of death.

Conclusion

COVID-19 is associated with clinical severity and excess mortality in patients with pulmonary embolism.

患者和方法2020年3月至2021年7月,在瓦加杜古的三所大学医院和一家私人诊所开展了一项回顾性数据收集的多中心横断面分析研究。研究对象包括经胸部CT血管造影证实患有肺栓塞,或经超声心动图多普勒检查证实患有急性肺动脉栓塞,并经下肢静脉超声多普勒检查证实患有深静脉血栓,且进行过COVID-19检测(RT-PCR或快速诊断检测)的连续住院患者。对照病例包括所有 COVID-19 阴性的 PE 病例。数据比较使用 Epi info 7 软件进行。通过单变量和多变量分析,对两个亚群的预后进行了比较。结果纳入了 96 例 COVID-19+ PE 患者和 70 例 COVID-19- PE 患者。因 COVID-19 住院的 PE 患者发病率为 7.05%。COVID-19+患者的平均年龄为(61.5±17)岁,COVID-19-患者的平均年龄为(49.6±15.9)岁。在 COVID-19+ 患者中,肺凝结综合征(P=0.007)、饱和度降低(P=0.0003)和呼吸窘迫综合征(P=0.006)更为常见。COVID-19+ 患者的住院死亡率为 27.1%,而 COVID-19- 患者的住院死亡率为 10%(P=0.0024)。结论COVID-19与肺栓塞患者的临床严重程度和超额死亡率有关。
{"title":"Pronostic comparé de l'embolie pulmonaire chez les patients infectés au COVID-19 et les patients non infectés au COVID-19 à Ouagadougou","authors":"Y. Kambiré ,&nbsp;G.R.C. Millogo ,&nbsp;K.J. Kologo ,&nbsp;A. Tall-Thiam ,&nbsp;V. Agossou ,&nbsp;L. Konaté ,&nbsp;H. Somé ,&nbsp;I. Diallo ,&nbsp;N.V. Yameogo ,&nbsp;K.A. Samadoulougou ,&nbsp;P. Zabsonré","doi":"10.1016/j.ancard.2024.101735","DOIUrl":"https://doi.org/10.1016/j.ancard.2024.101735","url":null,"abstract":"<div><h3>Objective</h3><p>the study's objective was to determine impact of COVID-19 on the prognosis of pulmonary embolism.</p></div><div><h3>Patients and methods</h3><p>An analytical multicenter cross-sectional study with retrospective data collection was carried out in three university hospitals and a private clinic in Ouagadougou from March, 2020 to July 2021. It included consecutive patients hospitalized for PE confirmed on chest CT angiography or by the association an acute cor pulmonale on echocardiography-Doppler with deep vein thrombosis on venous ultrasound-Doppler of the lower limbs and having carried out a COVID-19 test (RT-PCR or rapid diagnostic test). Control cases consisted of all COVID-19 negative PE cases. Data comparison was carried out using the Epi info 7 software. A univariate then multivariate analysis allowed the comparison of the prognosis of the two subpopulations. The significance level retained was <em>p</em> &lt; 0.05.</p></div><div><h3>Results</h3><p>96 patients with COVID-19+ and 70 COVID-19- PE were included. The prevalence of PE in patients hospitalized for COVID-19 was 7.05%. The average patient age was 61.5±17 years for COVID-19+ patients and 49.6±15.9 years for COVID-19- patients. Pulmonary condensation syndrome (<em>p</em>=0.007), desaturation (<em>p</em>=0.0003) and respiratory distress syndrome (<em>p</em>=0.006) were more common in COVID-19+ patients. The hospital death rate was 27.1% in COVID-19+ patients and 10% in COVID-19- patients (<em>p</em>=0.0024). Age &gt; 65 years and COVID-19 pneumonia were the independent factors of death.</p></div><div><h3>Conclusion</h3><p>COVID-19 is associated with clinical severity and excess mortality in patients with pulmonary embolism.</p></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101735"},"PeriodicalIF":0.3,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139914898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Takotsubo syndrome : A cause of reversible microvascular coronary dysfunction 高氏综合征:可逆性微血管冠状动脉功能障碍的病因
IF 0.3 Q4 Medicine Pub Date : 2024-02-14 DOI: 10.1016/j.ancard.2024.101734
Michel Zeitouni , Niki Procopi , Alban Redheuil , Jean-Philippe Collet

Since the first description of takotsubo syndrome 30 years ago, only a little is known on the underlying physiopathology leading to peculiar left ventricular function alteration and myocardial damage related to acute emotional or physical stress. In the present case, we used continuous invasive thermodilution to evaluate coronary microvascular function at the acute phase of takotsubo and after recovery. The acute phase of takotsubo was characterized by a reduced coronary output and altered reserved flow with persistently high resistance during hyperaemia. At 6 weeks, we described a complete recovery of microvascular function, concomitant to LVEF recovery.

自 30 年前首次描述拓扑综合征以来,人们对导致与急性情绪或身体应激有关的特殊左心室功能改变和心肌损伤的潜在生理病理学知之甚少。在本病例中,我们采用连续有创热稀释法评估了塔库洼综合征急性期和恢复后的冠状动脉微血管功能。高血压急性期的特点是冠状动脉输出量减少,预留血流量改变,高血症期间阻力持续较高。6 周后,我们发现微血管功能完全恢复,同时 LVEF 也恢复了。
{"title":"Takotsubo syndrome : A cause of reversible microvascular coronary dysfunction","authors":"Michel Zeitouni ,&nbsp;Niki Procopi ,&nbsp;Alban Redheuil ,&nbsp;Jean-Philippe Collet","doi":"10.1016/j.ancard.2024.101734","DOIUrl":"https://doi.org/10.1016/j.ancard.2024.101734","url":null,"abstract":"<div><p>Since the first description of takotsubo syndrome 30 years ago, only a little is known on the underlying physiopathology leading to peculiar left ventricular function alteration and myocardial damage related to acute emotional or physical stress. In the present case, we used continuous invasive thermodilution to evaluate coronary microvascular function at the acute phase of takotsubo and after recovery. The acute phase of takotsubo was characterized by a reduced coronary output and altered reserved flow with persistently high resistance during hyperaemia. At 6 weeks, we described a complete recovery of microvascular function, concomitant to LVEF recovery.</p></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101734"},"PeriodicalIF":0.3,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139732511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of upper septal fascicular ventricular tachycardia presented in a case report 一份罕见的室间隔上束室性心动过速病例报告
IF 0.3 Q4 Medicine Pub Date : 2024-02-13 DOI: 10.1016/j.ancard.2024.101738
Lorenzo Zaccaro , Stefano Avondo , Stefano Albani , Paolo Scacciatella

Case summary

A 71-year-old presented at the outpatient clinic with palpitations and NYHA II functional class. 12-lead ECG exhibited Upper septal idiopathic left ventricular tachycardia (US-ILVT). Ventricular tachycardia (VT) was interrupted with Verapamil administration, no further recurrences were documented after beta-blockers therapy was started. No coronary artery stenosis were detected. The US-ILVT was successfully treated by ablating the proximal site of the left anterior fascicle (LAF), where diastolic potential (P1) and pre-systolic potential (P2) with inverted sequence were detected during the electrophysiology study (EP) study. Cardiac magnetic resonance imaging (CMR) was performed with demonstration of intramyocardial late gadolinium enhancement (LGE) at the level of middle-basal portions of interventricular septum and basal portion of infero-lateral wall and no edema detection. A single catheter implantable cardioverter defibrillator (ICD) was implanted as secondary prevention. VT has never recurred during 3 months of follow-up with remote control of ICD.

Discussion

To the best of our knowledge, this is the first report in which US-ILVT was associated with ventricular septal LGE, suggestive of previous myocarditis, as substrate of re-entrant circuit. Scar-related ventricular tachycardia circuit is also suggested by the evidence of a premature ventricular complex (PVC) as trigger of recurrent VT in our case.

病例摘要 一位 71 岁的老人因心悸和 NYHA II 功能分级来到门诊就诊。12 导联心电图显示上隔特发性左室心动过速(US-ILVT)。使用维拉帕米后,室性心动过速(VT)被中断,开始使用β-受体阻滞剂治疗后没有再复发。未发现冠状动脉狭窄。通过消融左前束(LAF)的近端部位,成功治疗了 US-ILVT,在电生理学研究(EP)中检测到舒张期电位(P1)和收缩期前电位(P2)呈倒置序列。心脏磁共振成像(CMR)显示,室间隔中基底部分和下侧壁基底部分出现心内晚期钆增强(LGE),未发现水肿。作为二级预防,植入了单导管植入式除颤器(ICD)。据我们所知,这是第一例US-ILVT与室间隔LGE相关的报告,LGE提示既往有心肌炎,是再入电路的基底。在我们的病例中,室性早搏(PVC)是复发性室性心动过速的触发因素,这也提示了瘢痕相关室性心动过速回路。
{"title":"A rare case of upper septal fascicular ventricular tachycardia presented in a case report","authors":"Lorenzo Zaccaro ,&nbsp;Stefano Avondo ,&nbsp;Stefano Albani ,&nbsp;Paolo Scacciatella","doi":"10.1016/j.ancard.2024.101738","DOIUrl":"https://doi.org/10.1016/j.ancard.2024.101738","url":null,"abstract":"<div><h3>Case summary</h3><p>A 71-year-old presented at the outpatient clinic with palpitations and NYHA II functional class. 12-lead ECG exhibited Upper septal idiopathic left ventricular tachycardia (US-ILVT). Ventricular tachycardia (VT) was interrupted with Verapamil administration, no further recurrences were documented after beta-blockers therapy was started. No coronary artery stenosis were detected. The US-ILVT was successfully treated by ablating the proximal site of the left anterior fascicle (LAF), where diastolic potential (P1) and pre-systolic potential (P2) with inverted sequence were detected during the electrophysiology study (EP) study. Cardiac magnetic resonance imaging (CMR) was performed with demonstration of intramyocardial late gadolinium enhancement (LGE) at the level of middle-basal portions of interventricular septum and basal portion of infero-lateral wall and no edema detection. A single catheter implantable cardioverter defibrillator (ICD) was implanted as secondary prevention. VT has never recurred during 3 months of follow-up with remote control of ICD.</p></div><div><h3>Discussion</h3><p>To the best of our knowledge, this is the first report in which US-ILVT was associated with ventricular septal LGE, suggestive of previous myocarditis, as substrate of re-entrant circuit. Scar-related ventricular tachycardia circuit is also suggested by the evidence of a premature ventricular complex (PVC) as trigger of recurrent VT in our case.</p></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101738"},"PeriodicalIF":0.3,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139726875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aerococcus viridans might not be the cause in this case 在这种情况下,病毒性厌氧球菌可能不是病因。
IF 0.3 Q4 Medicine Pub Date : 2024-02-10 DOI: 10.1016/j.ancard.2023.101629
Nils Fernström, Magnus Rasmussen
{"title":"Aerococcus viridans might not be the cause in this case","authors":"Nils Fernström,&nbsp;Magnus Rasmussen","doi":"10.1016/j.ancard.2023.101629","DOIUrl":"10.1016/j.ancard.2023.101629","url":null,"abstract":"","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101629"},"PeriodicalIF":0.3,"publicationDate":"2024-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139717293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anomalie de connexion de l'artère coronaire droite au niveau de l'artère pulmonaire associée à une sténose du tronc commun gauche [右冠状动脉从肺动脉异常起源并伴有左主冠状动脉狭窄]。
IF 0.3 Q4 Medicine Pub Date : 2024-02-10 DOI: 10.1016/j.ancard.2024.101737
Omar Ait Mokhtar , Karima Hamidouche , Nadjet Amini , Younes Boudjemline , Abdelmalek Azzouz , Salim Benkhedda

We describe herein a case of a 16 years-old female patient referred to our department for further exploration of a chest pain. Color Doppler echocardiography revealed an abnormal flow at the level of the pulmonary artery. Exercise testing was abnormal leading to further imaging including computed cardiac tomography followed by coronary angiography which showed anomalous origin of the right coronary artery from the pulmonary artery (ARCAPA) associated with mid shaft left main stenosis. We discuss this uncommon association and therapeutic options.

我们在此描述一例因胸痛转诊至我科进一步检查的 16 岁女性患者。彩色多普勒超声心动图显示肺动脉水平血流异常。运动测试异常导致进一步的成像检查,包括心脏计算机断层扫描和冠状动脉造影,结果显示肺动脉右冠状动脉起源异常(ARCAPA)与中轴左主干狭窄有关。我们将讨论这种不常见的关联和治疗方案。
{"title":"Anomalie de connexion de l'artère coronaire droite au niveau de l'artère pulmonaire associée à une sténose du tronc commun gauche","authors":"Omar Ait Mokhtar ,&nbsp;Karima Hamidouche ,&nbsp;Nadjet Amini ,&nbsp;Younes Boudjemline ,&nbsp;Abdelmalek Azzouz ,&nbsp;Salim Benkhedda","doi":"10.1016/j.ancard.2024.101737","DOIUrl":"10.1016/j.ancard.2024.101737","url":null,"abstract":"<div><p>We describe herein a case of a 16 years-old female patient referred to our department for further exploration of a chest pain. Color Doppler echocardiography revealed an abnormal flow at the level of the pulmonary artery. Exercise testing was abnormal leading to further imaging including computed cardiac tomography followed by coronary angiography which showed anomalous origin of the right coronary artery from the pulmonary artery (ARCAPA) associated with mid shaft left main stenosis. We discuss this uncommon association and therapeutic options.</p></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"73 2","pages":"Article 101737"},"PeriodicalIF":0.3,"publicationDate":"2024-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139717292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annales de cardiologie et d'angeiologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1